References

  1. Canadian Hemophilia Society. All About von Willebrand Disease...for people with von Willebrand disease and their families. 2011. http://www.hemophilia.ca/files/All%20About%20VWD%202011%20-%20FINAL.pdf. Accessed June 1, 2017.
  2. Facts about von Willebrand disease. Centers for Disease Control and Prevention website. https://www.cdc.gov/ncbddd/vWd/facts.html. Updated November 17, 2016. Accessed June 1, 2017.
  3. National Hemophilia Foundation. Strategic Summit on von Willebrand Disease. 2015. https://www.hemophilia.org/sites/default/files/article/documents/NHF-Strategic-Summit-Report-on-von-Willebrand-disease_1.pdf. Accessed June 1, 2017.
  4. VONVENDI Prescribing Information.
  5. Stockschlaeder M, Schneppenheim R, Budde U. Update on von Willebrand factor multimers: focus on high molecular-weight multimers and their role in hemostasis. Blood Coagul Fibrinolysis. 2014;25:206-216.
  6. Nichols WL, Hultin MB, James AH, et al. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14(2):171-232.
  7. Gill JC, Castaman G, Windyga J, et al. Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease. Blood. 2015;126(17):2038-2046.